Recurrent Hypoglycemia Triggered by Sorafenib Therapy in a Patient with Hemangiopericytoma

Targeted therapy has been proven to be one of the most effective cancer treatments. However, some endocrine disorders can occur during treatment with targeted agents. We report the case of a patient who exhibited a wax and wane pattern of hypoglycemia that was attributed to sorafenib therapy. A 32-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Si Won, Lee, Eun Kyung, Yun, Tak, Won, Young-Woong, Ko, Eun Jeong, Choi, Mihong, Choi, Sang Il, Park, Sun Seob, Hong, Eun Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091496/
https://www.ncbi.nlm.nih.gov/pubmed/25031894
http://dx.doi.org/10.3803/EnM.2014.29.2.202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091496/
https://www.ncbi.nlm.nih.gov/pubmed/25031894
http://dx.doi.org/10.3803/EnM.2014.29.2.202

Ejemplares similares